| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Skye Bioscience, Inc. | Chief Development Officer | Stock Option (Right to Buy) | 125,000 | 06 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 06 Feb 2026 | 1 | $0 | 4 | Chief Development Officer | 09 Feb 2026, 20:54 |
| SKYE | Skye Bioscience, Inc. | 24 Feb 2025 | 1 | $0 | 4 | Chief Development Officer | 26 Feb 2025, 17:38 |
| SKYE | Skye Bioscience, Inc. | 15 Nov 2024 | 2 | -$97,722 | 4 | Chief Development Officer | 20 Nov 2024, 08:23 |
| SKYE | Skye Bioscience, Inc. | 28 Oct 2024 | 1 | $0 | 4 | Chief Development Officer | 30 Oct 2024, 20:33 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 2 | $0 | 4 | Chief Development Officer | 04 Mar 2024, 06:19 |
| SKYE | Skye Bioscience, Inc. | 29 Feb 2024 | 0 | $0 | 3 | Chief Development Officer | 04 Mar 2024, 06:17 |